Skip to main content

Chest Congestion Relief

NDC 0536-1314 · RUGBY LABORATORIES

Generic nameGuaifenesin
Dosage formLIQUID
RouteORAL
Active ingredient(s)GUAIFENESIN
Strength100 mg/5mL
Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
Marketing categoryOTC MONOGRAPH DRUG

Packages

0536-1314-85 — 473 mL in 1 BOTTLE (0536-1314-85)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0363-9946 — Guaifenesin and Pseudoephedrine HCl, 0485-0208 — GUAIFENESIN and PHENYLEPHRINE, 0536-1161 — Guaifenesin, Dextromethorphan HBr, 0536-1163 — Guaifenesin, 0536-1213 — Guaifenesin, Dextromethorphan HBr, 0536-1249 — Guaifenesin, 0536-1309 — Guaifenesin/phenylephrine, 0536-1311 — Guaifenesin, 0536-1312 — Dextromethorphan Hydrobromide / Guaifenesin, 0536-1313 — Dextromethorphan Hydrobromide, Guaifenesin, 0536-1333 — Guaifenesin and Pseudoephedrine Hydrochloride, 0536-1348 — dextromethorphan hydrobromide, guaifenesin, 0536-1392 — Guaifenesin, 0536-1430 — Guaifenesin, 0536-1446 — dextromethorphan hydrobromide, guaifenesin, 0536-1447 — dextromethorphan hydrobromide, guaifenesin, 0536-1449 — guaifenesin and pseudoephedrine hydrochloride, 0536-1451 — guaifenesin, 0536-1489 — guaifenesin, 0615-8637 — Guaifenesin, +1437 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources